{"pmid":32501130,"title":"Novel Coronavirus disease 2019 (COVID-19): new challenges and new responsibilities in developing countries.","text":["Novel Coronavirus disease 2019 (COVID-19): new challenges and new responsibilities in developing countries.","Novel coronavirus disease 2019 (COVID-19) is caused by the SARS-CoV-2 virus, which belongs to the genus Coronaviridae with its high mutation rate. From the current perspective, we discuss the current status of COVID-19, new challenges, and potential interventions to control the pandemic in developing counties such as Pakistan.","Hum Vaccin Immunother","Anjum, Faisal Rasheed","Anam, Sidra","Rahman, Sajjad Ur","32501130"],"abstract":["Novel coronavirus disease 2019 (COVID-19) is caused by the SARS-CoV-2 virus, which belongs to the genus Coronaviridae with its high mutation rate. From the current perspective, we discuss the current status of COVID-19, new challenges, and potential interventions to control the pandemic in developing counties such as Pakistan."],"journal":"Hum Vaccin Immunother","authors":["Anjum, Faisal Rasheed","Anam, Sidra","Rahman, Sajjad Ur"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32501130","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1080/21645515.2020.1766939","keywords":["covid-19","interventions","pandemic","vaccination"],"locations":["Pakistan"],"countries":["Pakistan"],"countries_codes":["PAK|Pakistan"],"topics":["Prevention"],"weight":1,"_version_":1668890966475407361,"score":9.490897,"similar":[{"pmid":32023682,"title":"[2019-nCoV: new challenges from coronavirus].","text":["[2019-nCoV: new challenges from coronavirus].","The outbreak of pneumonia caused by the novel coronavirus 2019-nCoV in Wuhan, Hubei province of China, at the end of 2019 shaped tremendous challenges to China's public health and clinical treatment. The virus belongs to the beta genus Coronavirus in the family Corornaviridae, and is closely related to SARS-CoV and MERS-CoV, causing severe symptoms of pneumonia. The virus is transmitted through droplets, close contact, and other means, and patients in the incubation period could potentially transmit the virus to other persons. According to current observations, 2019-nCoV is weaker than SARS in pathogenesis, but has stronger transmission competence; it's mechanism of cross-species spread might be related with angiotensin-converting enzyme (ACE2), which is consistent with the receptor SARS-CoV. After the outbreak of this disease, Chinese scientists invested a lot of energy to carry out research by developing rapid diagnostic reagents, identifying the characters of the pathogen, screening out clinical drugs that may inhibit the virus, and are rapidly developing vaccines. The emergence of 2019-nCoV reminds us once again of the importance of establishing a systematic coronavirus surveillance network. It also poses new challenges to prevention and control of the emerging epidemic and rapidly responses on scientific research.","Zhonghua Yu Fang Yi Xue Za Zhi","Tian, H Y","32023682"],"abstract":["The outbreak of pneumonia caused by the novel coronavirus 2019-nCoV in Wuhan, Hubei province of China, at the end of 2019 shaped tremendous challenges to China's public health and clinical treatment. The virus belongs to the beta genus Coronavirus in the family Corornaviridae, and is closely related to SARS-CoV and MERS-CoV, causing severe symptoms of pneumonia. The virus is transmitted through droplets, close contact, and other means, and patients in the incubation period could potentially transmit the virus to other persons. According to current observations, 2019-nCoV is weaker than SARS in pathogenesis, but has stronger transmission competence; it's mechanism of cross-species spread might be related with angiotensin-converting enzyme (ACE2), which is consistent with the receptor SARS-CoV. After the outbreak of this disease, Chinese scientists invested a lot of energy to carry out research by developing rapid diagnostic reagents, identifying the characters of the pathogen, screening out clinical drugs that may inhibit the virus, and are rapidly developing vaccines. The emergence of 2019-nCoV reminds us once again of the importance of establishing a systematic coronavirus surveillance network. It also poses new challenges to prevention and control of the emerging epidemic and rapidly responses on scientific research."],"journal":"Zhonghua Yu Fang Yi Xue Za Zhi","authors":["Tian, H Y"],"date":"2020-02-06T11:00:00Z","year":2020,"_id":"32023682","source":"PubMed","week":"20206|Feb 03 - Feb 09","doi":"10.3760/cma.j.issn.0253-9624.2020.0001","keywords":["2019-ncov","coronavirus","public health"],"locations":["Wuhan","Hubei","China","China","Chinese"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Prevention","Transmission","Treatment"],"weight":1,"_version_":1666138490894548992,"score":119.53764},{"pmid":32380441,"pmcid":"PMC7195042","title":"Psychological interventions during COVID-19: Challenges for low and middle income countries.","text":["Psychological interventions during COVID-19: Challenges for low and middle income countries.","At the start of 2020, the 2019 coronavirus disease (COVID-19), originating from China has spread to the world. There have been increasing numbers of confirmed cases and deaths around the globe. The COVID-19 pandemic has paved the way for considerable psychological and psychosocial morbidity among the general public and health care providers. An array of guidelines has been put forward by multiple agencies for combating mental health challenges. This paper addresses some of the mental health challenges faced by low and middle income countries (LMIC). It is worthwhile to note that these are challenges at the current stage of the pandemic and may change with the course of the pandemic itself.","Asian J Psychiatr","De Sousa, Avinash","Mohandas, E","Javed, Afzal","32380441"],"abstract":["At the start of 2020, the 2019 coronavirus disease (COVID-19), originating from China has spread to the world. There have been increasing numbers of confirmed cases and deaths around the globe. The COVID-19 pandemic has paved the way for considerable psychological and psychosocial morbidity among the general public and health care providers. An array of guidelines has been put forward by multiple agencies for combating mental health challenges. This paper addresses some of the mental health challenges faced by low and middle income countries (LMIC). It is worthwhile to note that these are challenges at the current stage of the pandemic and may change with the course of the pandemic itself."],"journal":"Asian J Psychiatr","authors":["De Sousa, Avinash","Mohandas, E","Javed, Afzal"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32380441","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.ajp.2020.102128","keywords":["covid-19","interventions","low and middle income countries","pandemic","psychiatric","psychological"],"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"weight":0,"_version_":1666597097410920448,"score":101.61305},{"pmid":32363707,"title":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review.","text":["Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review.","Coronaviruses are a class of RNA viruses that can cause respiratory and intestinal infections in animals and humans. SARS-CoV, MERS-CoV and a novel coronavirus (SARS-CoV-2 [2019-nCoV]) belong to the family Coronaviridae and the genus Betacoronavirus. At present, the understanding of SARS-CoV-2 is getting deeper and deeper. In order to better prevent and treat SARS-CoV-2, this article compares the infectivity, pathogenicity, and related clinical characteristics of the three human pathogenic coronaviruses, SARS-CoV-2, SARS-CoV and MERS-CoV to help us further understand the pathogenic characteristics of novel coronaviruses.","APMIS","Liya, Guo","Yuguang, Wang","Jian, Liu","Huaiping, Yuan","Xue, Han","Jianwei, Huo","Jiaju, Ma","Youran, Lu","Chen, Ming","Yiqing, Jiao","32363707"],"abstract":["Coronaviruses are a class of RNA viruses that can cause respiratory and intestinal infections in animals and humans. SARS-CoV, MERS-CoV and a novel coronavirus (SARS-CoV-2 [2019-nCoV]) belong to the family Coronaviridae and the genus Betacoronavirus. At present, the understanding of SARS-CoV-2 is getting deeper and deeper. In order to better prevent and treat SARS-CoV-2, this article compares the infectivity, pathogenicity, and related clinical characteristics of the three human pathogenic coronaviruses, SARS-CoV-2, SARS-CoV and MERS-CoV to help us further understand the pathogenic characteristics of novel coronaviruses."],"journal":"APMIS","authors":["Liya, Guo","Yuguang, Wang","Jian, Liu","Huaiping, Yuan","Xue, Han","Jianwei, Huo","Jiaju, Ma","Youran, Lu","Chen, Ming","Yiqing, Jiao"],"date":"2020-05-05T11:00:00Z","year":2020,"_id":"32363707","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1111/apm.13047","keywords":["mers-cov","sars-cov","sars-cov-2","clinical features","pneumonia"],"topics":["Treatment","Mechanism","Diagnosis"],"weight":1,"_version_":1666138495961268224,"score":95.66328},{"pmid":32259829,"pmcid":"PMC7179549","title":"COVID-19 Outbreak: An Overview.","text":["COVID-19 Outbreak: An Overview.","BACKGROUND: In late December 2019, Chinese health authorities reported an outbreak of pneumonia of unknown origin in Wuhan, Hubei Province. SUMMARY: A few days later, the genome of a novel coronavirus was released (http://viro-logical.org/t/novel-2019-coronavirus-genome/319; Wuhan-Hu-1, GenBank accession No. MN908947) and made publicly available to the scientific community. This novel coronavirus was provisionally named 2019-nCoV, now SARS-CoV-2 according to the Coronavirus Study Group of the International Committee on Taxonomy of Viruses. SARS-CoV-2 belongs to the Coronaviridae family, Betacoronavirus genus, subgenus Sarbecovirus. Since its discovery, the virus has spread globally, causing thousands of deaths and having an enormous impact on our health systems and economies. In this review, we summarize the current knowledge about the epidemiology, phylogenesis, homology modeling, and molecular diagnostics of SARS-CoV-2. Key Messages: Phylogenetic analysis is essential to understand viral evolution, whereas homology modeling is important for vaccine strategies and therapies. Highly sensitive and specific diagnostic assays are key to case identification, contact tracing, identification of the animal source, and implementation of control measures.","Chemotherapy","Ciotti, Marco","Angeletti, Silvia","Minieri, Marilena","Giovannetti, Marta","Benvenuto, Domenico","Pascarella, Stefano","Sagnelli, Caterina","Bianchi, Martina","Bernardini, Sergio","Ciccozzi, Massimo","32259829"],"abstract":["BACKGROUND: In late December 2019, Chinese health authorities reported an outbreak of pneumonia of unknown origin in Wuhan, Hubei Province. SUMMARY: A few days later, the genome of a novel coronavirus was released (http://viro-logical.org/t/novel-2019-coronavirus-genome/319; Wuhan-Hu-1, GenBank accession No. MN908947) and made publicly available to the scientific community. This novel coronavirus was provisionally named 2019-nCoV, now SARS-CoV-2 according to the Coronavirus Study Group of the International Committee on Taxonomy of Viruses. SARS-CoV-2 belongs to the Coronaviridae family, Betacoronavirus genus, subgenus Sarbecovirus. Since its discovery, the virus has spread globally, causing thousands of deaths and having an enormous impact on our health systems and economies. In this review, we summarize the current knowledge about the epidemiology, phylogenesis, homology modeling, and molecular diagnostics of SARS-CoV-2. Key Messages: Phylogenetic analysis is essential to understand viral evolution, whereas homology modeling is important for vaccine strategies and therapies. Highly sensitive and specific diagnostic assays are key to case identification, contact tracing, identification of the animal source, and implementation of control measures."],"journal":"Chemotherapy","authors":["Ciotti, Marco","Angeletti, Silvia","Minieri, Marilena","Giovannetti, Marta","Benvenuto, Domenico","Pascarella, Stefano","Sagnelli, Caterina","Bianchi, Martina","Bernardini, Sergio","Ciccozzi, Massimo"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32259829","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1159/000507423","keywords":["covid-19","pandemic","phylogenesis","protein modeling","real-time polymerase chain reaction","sars-cov-2"],"locations":["Chinese","Wuhan","Hubei","Sarbecovirus"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Mechanism"],"weight":1,"_version_":1666138493082927104,"score":94.51583},{"pmid":32270884,"title":"Role of Nonstructural Proteins in the Pathogenesis of SARS-CoV-2.","text":["Role of Nonstructural Proteins in the Pathogenesis of SARS-CoV-2.","We read with great interest the study authored by Angeletti et al. regarding the role of nonstructural proteins nsp2 and nsp3 in the pathogenesis of COVID-19(1) . COVID-19 emerged in December 2019 in Wuhan City, Hubei Province, China and is caused by a novel viral variant belonging to the viral variant belonging to the Severe acute respiratory syndrome-related coronavirus (SARS-rCoV) species of subgenus Sarbecovirus, genus Betacoronavirus, family Coronaviridae and named SARS-CoV-2(2) . This article is protected by copyright. All rights reserved.","J Med Virol","da Silva, Severino Jefferson Ribeiro","da Silva, Caroline Targino Alves","Mendes, Renata Pessoa Germano","Pena, Lindomar","32270884"],"abstract":["We read with great interest the study authored by Angeletti et al. regarding the role of nonstructural proteins nsp2 and nsp3 in the pathogenesis of COVID-19(1) . COVID-19 emerged in December 2019 in Wuhan City, Hubei Province, China and is caused by a novel viral variant belonging to the viral variant belonging to the Severe acute respiratory syndrome-related coronavirus (SARS-rCoV) species of subgenus Sarbecovirus, genus Betacoronavirus, family Coronaviridae and named SARS-CoV-2(2) . This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["da Silva, Severino Jefferson Ribeiro","da Silva, Caroline Targino Alves","Mendes, Renata Pessoa Germano","Pena, Lindomar"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32270884","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1002/jmv.25858","locations":["Wuhan","Hubei","China","Sarbecovirus"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1666138491748089856,"score":93.66967}]}